Table 1 Patients baseline characteristics according to study group
Parameters | Standard infusion line (n = 86) | Optimised infusion line (n = 86) |
|---|---|---|
Age (years) | 62.6 ± 10.3 (63.0) | 61.8 ± 10.5 (61.0) |
BMI (kg.m−2) | 25.5 ± 5.2 (25.0) | 25.5 ± 4.9 (25.9) |
Men, n (%) | 33 (38.4) | 27 (31.4) |
ASA score, n (%) | ||
ASA 1 | 11 (12.8) | 17 (19.8) |
ASA 2 | 56 (65.1) | 55 (63.9) |
ASA 3 | 18 (20.9) | 13 (15.1) |
ASA 4 | 1 (1.2) | 1 (1.2) |
Number of CRFs, n (%) | ||
0 | 14 (17.5) | 9 (11.0) |
1 | 10 (25.0) | 23 (28.0) |
2 | 9 (11.3) | 20 (24.4) |
3 | 37 (46.2) | 30 (36.6) |
Dyslipidemia, n (%) | 30 (37.5) | 27 (32.9) |
High blood pressure, n (%) | 37 (46.3) | 39 (47.6) |
Pulmonary history, n (%) | 11 (13.8) | 15 (18.3) |
Cirrhosis history, n (%) | 8 (10.0) | 4 (4.9) |
Liver surgery history, n (%) | 8 (10.0) | 6 (7.3) |
Pancreas disease history, n (%) | 4 (5.0) | 3 (3.7) |
Corticosteroid therapy, n (%) | 1 (1.3) | 4 (4.9) |
Kidney disease history, n (%) | 2 (2.5) | 3 (3.7) |
Blood disease history, n (%) | 2 (2.5) | 2 (2.4) |
Pre-existing diabetes, n (%) | 17 (21.3) | 12 (14.6) |
Scheduled surgery, n (%) | 85 (98.8) | 84 (97.7) |
Type of surgery, n (%) | ||
Esophagus | 33 (41.3) | 34 (41.5) |
Liver | 29 (36.3) | 31 (37.8) |
Pancreas | 8 (10.0) | 8 (9.8) |
Vascular and general | 10 (12.5) | 9 (11.0) |
SAPS II | 22.2 ± 8.4 (23.0) | 21.8 ± 7.9 (21.0) |
SOFA score | 1.3 ± 1.8 (0.0) | 1.2 ± 1.7 (0.0) |